Publications/ Eng

Clinical Intervention Model (CIM)

5-azacitidine use in Quebec’s University Teaching HospitalsCIM, descriptive analysis, 2015

Abbreviations and symbols used on prescriptions in Quebec’s University Teaching hospitalsCIM, descriptive analysis,  2016

Antifungal use in Quebec’s University Teaching HospitalsCIM, descriptive analysis, 2017

Antifungals – Treatment of Yeast Fungemia and Candidemia – Treatment Algorithm (August 2019 version):

Biosimilars: State of Knowledge and Recommendations for Quebec’s University Teaching  HospitalsCIM, Comprehensive evaluation, 2017

Bortezomib use in Quebec’s University Teaching HospitalsCIM, descriptive analysis, 2015

Dexmedetomidine use in intensive care in Quebec’s University Teaching Hospitals based on the utilization criteria established by the TDMP in 2010CIM, descriptive analysis, 2010

Evaluation of micafungin (Mycamine™) for the treatment and prevention of Candida infections in pediatric patients – CIM, summary evaluation 2018

The use of Filgrastim in Quebec’s university teaching hospitals (UTHs)CIM, descriptive analysis, 2018

Descriptive analysis of the pediatric use of filgrastim in Quebec’s university teaching hospitals (UTHs)CIM, descriptive analysis, 2018

Ipilimumab in the Treatment of Metastatic or Unresectable Advanced Melanoma in Quebec’s University Teaching Hospitals – CIM, descriptive analysis, 2016

Nivolumab (Opdivo™) – What is the preferred strategy: a weight-based dosage, a fixed dose or a weight-based dosage with a maximum dose? – CIM, summary evaluation 2018

Pembrolizumab (Keytruda™) – What is the preferred strategy: a weight-based dosage, a fixed dose, or a weight-based dosage with a maximum dose? – CIM, summary evaluation 2018

Pertuzumab/trastuzumab in HER-2 positive metastatic breast cancerCIM, descriptive analysis, 2019

Prescribing and use of Rituximab as Maintenance Therapy for Follicular Lymphoma in Quebec’s University Teaching Hospitals – CIM, summary evaluation 2013

Surgical Antibiotic Prophylaxis in Quebec’s University Teaching HospitalsCIM, descriptive analysis, 2014

Drug evaluations

Descriptive analysis/drug utilization reviews

Treatment review

Posters

Descriptive Analysis of Filgrastim Use in Children in Four University Teaching Hospitals in Québec, Canada (CAPhO 2019), April 2019, Halifax

A clinical intervention model for knowledge transfer: Treatment of candidemia (AMCTS), April 2019, Edmonton

Descriptive Analysis of Filgrastim use in four adult University  Teaching Hospital in Quebec(CAPhO 2018), May 2018, Ottawa-Gatineau.

Biosimilars : State of knowledge and recommendation from the Programme de gestion thérapeutique des médicaments  – ACMTS, April 2018,Halifax

Descriptive Analysis of antifungals use in five university teaching hospitals in QuebecASM Microbe June 2017

5-Azacitidine descriptive analysis – CAPhO 2016, Niagara Falls, April 2016

Bortezomib descriptive analysis CAPhO 2016, Niagara Falls, April 2016

Descriptive analysis and utilization review of meropenem in five university teaching hospitals ICAAC, September 2011 

Publications/abstracts

Real-life use of nivolumab and pembrolizumab in four adult university teaching hospitals in Québec, Canada. Abstract published in Journal of Clinical Oncology – May 2019

Descriptive analysis of the use of ipilimumab (IPI) in previously treated patients with unresectable stage III or IV metastatic melanoma (MM) in four university hospitals of Quebec, Canada. Abstract published in Journal of Clinical Oncology – May 2016

Descriptive Analysis of Azacitidine Use in Four Adult University Teaching Hospitals in Quebec, Canada. Abstract published in Blood (journal) – December 2015

Descriptive Analysis of Bortezomib Use in Multiple Myeloma in Four Adult University Teaching Hospitals in Quebec, Canada. Abstract published in Blood (journal) – December 2015

Presentations

Advertisements
Advertisements
%d blogueurs aiment ce contenu :